Narcolepsy
Also known as: Narcolepsy without cataplexy / (CNS disorders NOS) or (narcolepsy) or (Ondine's curse) or (Schilder's disease) / Narcolepsy (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00182 | Amphetamine | A CNS stimulant and sympathomimetic agent indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). |
| DB06413 | Armodafinil | A stimulant used to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea, narcolepsy, or shift work disorder. |
| DB01576 | Dextroamphetamine | A sympathomimetic agent used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. |
| DB01364 | Ephedrine | An alpha and beta-adrenergic agonist indicated to treat hypotension under anesthesia, allergic conditions, bronchial asthma, and nasal congestion. |
| DB01577 | Metamfetamine | A sympathomimetic agent used in the treatment of attention deficit hyperactivity disorder (ADHD) and exogenous obesity. |
| DB00422 | Methylphenidate | A stimulant used in the management of Attention Deficit Hyperactivity Disorder (ADHD). |
| DB00745 | Modafinil | A stimulant used to improve wakefulness in patients with sleep apnea, narcolepsy, or shift work disorder. |
| DB11642 | Pitolisant | An antagonist and inverse agonist at the histamine H3 receptor that is used to treat narcolepsy in adults. |
| DB09072 | Sodium oxybate | A central nervous system depressant used to treat cataplexy and excessive daytime sleepiness (EDS) associated with narcolepsy. |
| DB14754 | Solriamfetol | Solriamfetol is indicated for treatment of daytime sleepiness associated with obstructive sleep apnea and narcolepsy, but is not a treatment for the underlying airway obstruction in apnea patients[FDA Label][A176534,A176744]. |